IBRX — Immunitybio Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates IBRX Bullish with a Setup Score of 54, net conviction 67, actionability 44. How the Setup Score works →

Total Setup Score54
Directional BiasBullish
Net Conviction67
Actionability44 (in range)

Key signals behind this score

About Immunitybio Inc

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$8.22
Market Cap$9.29B
Float394.2M
Shares Outstanding1.05B
Price/Sales (TTM)65.90
vs. Analyst Target+58.2% to analyst PT
Operating Margin (TTM)-157.88%
Revenue (TTM)$141M
Dividend RateNone
Analyst Target Price$13.00 (5 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $605,000 -$222M $605,000 -$204M
2021 $934,000 -$347M $934,000 -$321M
2022 $240,000 -$417M $240,000 -$352M
2023 $622,000 -$583M $622,000 -$479M
2024 $14.7M -$414M $14.7M -$264M
2025 $113M -$351M $113M -$224M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $26.4M -$92.6M
Sep 2025 $32.1M -$67.3M
Dec 2025 $38.3M -$61.9M
Mar 2026 $44.2M -$633M

Ownership & Float

Insider Ownership62.5%
Institutional Ownership17.6%
Short Float34.3%
% of All Funds Holding4.38%
Number of Funds Holding360

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$7.90Near-term / short-term trend
Weekly40-Week SMA$5.72Medium-term trend
Weekly80-Week SMA$4.25Cyclical trend (business cycle)
Weekly200-Week SMA$4.17Secular trend (multi-year)
Monthly10-Month SMA$6.20Near-term monthly trend
Monthly20-Month SMA$4.47Medium-term monthly trend
Monthly40-Month SMA$4.31Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$9.60 resistance 1.57x 3 months ago
$6.30 support 2.10x 4 months ago
$2.10 support 3.60x 5 months ago

Historical Earnings Reactions (44 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.33% 0.19% 52.27% 29.15% -55.71%
1 Day -0.80% -1.49% 43.18% 39.75% -55.14%
1 Week -0.78% -1.00% 45.45% 57.22% -54.82%
2 Weeks -0.16% 0.10% 50.00% 55.19% -61.74%
1 Month -1.85% -3.77% 47.73% 117.97% -63.90%

Next earnings: August 4, 2026 (22 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan21.9%36.4%11
Feb7.6%54.5%11
Mar-9.6%27.3%11
Apr1.3%45.5%11
May5.5%45.5%11
Jun13.5%36.4%11
Jul-2.9%40.0%10
Aug-11.0%27.3%11
Sep-3.4%36.4%11
Oct3.0%45.5%11
Nov12.2%63.6%11
Dec4.9%36.4%11

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.80% 45.1% 514
Tuesday -0.27% 42.2% 566
Wednesday 0.11% 46.6% 564
Thursday -0.23% 42.2% 554
Friday 0.54% 48.6% 551

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 17.6%

Insider Transactions — Smart Summary

Total insider ownership: 62.5%

Founder-led management: Patrick Soon-Shiong (Founder, Executive Chairman and Global Chief Scientific & Medical Officer)

12-Month Insider Activity Summary

Total Filings10
Net Value+N/A
Net Shares Change-516,014
% of Float-0.1%
C-Suite Filings0
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Simon Barry J. -$4.2M 5 N/A
Selecky Christobel -$1.9M 4 N/A
Cohen Cheryl -$1.1M 1 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-06-26 – 2026-07-06 4 3 -$2.8M

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-07-06 Cohen Cheryl -$1.1M Transaction at $6.24, now +31.7%
2026-02-24 Simon Barry J. -$1.8M Transaction at $9.45, now -13.0%
2026-01-21 Simon Barry J. -$1.1M Transaction at $7.20, now +14.2%
2026-02-26 Simon Barry J. -$900,787.5 Transaction at $12.01, now -31.6%
2026-07-06 Selecky Christobel -$962,577.312 Transaction at $6.01, now +36.9%
2026-07-01 Selecky Christobel -$586,841.391 Transaction at $5.97, now +37.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Immunitybio Inc (IBRX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for IBRX on Trend Edge →